C4X Discovery
Curated by SignalDeveloper of optimized drug discovery and design services
Overview
Developer of optimized drug discovery and design services. The company has two proprietary and synergistic software platforms Taxonomy3, a human genetics analysis platform, and Conformetrix, which determines the 3D shape of drug molecules. The company's NMR technology provides templates for drug discovery and design and information for drug candidate optimization. The company's pipeline has candidates for the treatment of addiction (Oral Orexin-1 Antagonist), diabetes (oral GPR142 and GLP-1 agonists), inflammation, and oncology.
Key facts
- Founded
- 2008
- Headquarters
- Manchester, United Kingdom
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Business model
- 4 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view
- Phone
- Sign up to view